Azelnidipine, a novel calcium channel blocker, ameliorates severity of colitis in DSS induced colitis in mice possibly by modulating tissue levels of TNF-alpha and IL-6
Copy For Citation
KAV T., AKYOL A., KAHRAMANOĞLU AKSOY E., ÖZER C., TORGUTALP M., SİVRİ B.
12th Congress of ECCO, Barselona, Spain, 15 February 2017 - 18 February 2018, vol.11, pp.93-94
-
Publication Type:
Conference Paper / Summary Text
-
Volume:
11
-
Doi Number:
10.1093/ecco-jcc/jjx002.155
-
City:
Barselona
-
Country:
Spain
-
Page Numbers:
pp.93-94
-
Hacettepe University Affiliated:
Yes